Vermillion, Inc.
Records under this name other than patents Vermillion, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,951,529 | Biomarkers for breast cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,465,929 | Biomarkers for Ovarian Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 7,761,239 | Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,206,934 | Methods for diagnosing ovarian cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,221,984 | Biomarkers for ovarian cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,274,118 | Predictive Markers for Ovarian Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 9,846,158 | Predictive Biomarkers for Ovarian Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 10,605,811 | Predictive Biomarkers for Ovarian Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 7,867,719 | BETA-2 Microglobulin as a Biomarker for Peripheral Artery Disease Formerly held In force · High confidence | In force | High confidence | |
| US 8,664,358 | Predictive Markers for Ovarian Cancer Formerly held In force · High confidence | In force | High confidence |